 Andra Dingman
Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infarction, Middle Cerebral Artery | 2 | 2023 | 39 | 0.830 |
Why?
| | Stroke | 5 | 2023 | 1071 | 0.740 |
Why?
| | Nervous System Diseases | 1 | 2022 | 252 | 0.660 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2017 | 34 | 0.550 |
Why?
| | Brain Ischemia | 4 | 2022 | 321 | 0.510 |
Why?
| | Craniocerebral Trauma | 1 | 2017 | 152 | 0.500 |
Why?
| | Seizures | 1 | 2017 | 402 | 0.450 |
Why?
| | Parents | 1 | 2022 | 1309 | 0.440 |
Why?
| | Child Abuse | 1 | 2017 | 517 | 0.380 |
Why?
| | Animals, Newborn | 2 | 2023 | 835 | 0.220 |
Why?
| | Cerebrovascular Disorders | 1 | 2024 | 90 | 0.220 |
Why?
| | Brain | 5 | 2024 | 2679 | 0.220 |
Why?
| | Cerebrovascular Circulation | 1 | 2024 | 226 | 0.200 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 277 | 0.190 |
Why?
| | Myelin Sheath | 1 | 2023 | 160 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 4 | 2020 | 3408 | 0.180 |
Why?
| | Oligodendroglia | 1 | 2023 | 166 | 0.180 |
Why?
| | Cognition | 2 | 2019 | 1123 | 0.170 |
Why?
| | Nervous System Malformations | 1 | 2020 | 37 | 0.170 |
Why?
| | Hydrocephalus | 1 | 2020 | 107 | 0.160 |
Why?
| | Nogo Proteins | 1 | 2019 | 9 | 0.160 |
Why?
| | Intracranial Hemorrhages | 1 | 2019 | 80 | 0.160 |
Why?
| | Temporal Lobe | 1 | 2019 | 87 | 0.160 |
Why?
| | Biomedical Research | 1 | 2024 | 638 | 0.150 |
Why?
| | Neuroprotection | 1 | 2018 | 38 | 0.150 |
Why?
| | CA1 Region, Hippocampal | 1 | 2019 | 52 | 0.150 |
Why?
| | Infant, Newborn, Diseases | 1 | 2019 | 110 | 0.150 |
Why?
| | Infant | 2 | 2022 | 9024 | 0.130 |
Why?
| | Decision Making | 1 | 2022 | 851 | 0.120 |
Why?
| | Estradiol | 1 | 2018 | 494 | 0.120 |
Why?
| | Electroencephalography | 1 | 2017 | 403 | 0.120 |
Why?
| | Heart Arrest | 1 | 2018 | 321 | 0.120 |
Why?
| | Recovery of Function | 1 | 2017 | 642 | 0.110 |
Why?
| | Animals | 9 | 2024 | 35361 | 0.100 |
Why?
| | Critical Care | 1 | 2017 | 553 | 0.100 |
Why?
| | Signal Transduction | 2 | 2019 | 4925 | 0.100 |
Why?
| | Neuroprotective Agents | 2 | 2018 | 122 | 0.090 |
Why?
| | Mice | 4 | 2023 | 16937 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2742 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1776 | 0.080 |
Why?
| | Cohort Studies | 1 | 2017 | 5420 | 0.070 |
Why?
| | Pregnancy Complications | 1 | 2011 | 493 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1198 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2022 | 4063 | 0.060 |
Why?
| | Minocycline | 1 | 2005 | 27 | 0.060 |
Why?
| | Humans | 7 | 2024 | 129650 | 0.060 |
Why?
| | Placenta | 1 | 2011 | 723 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2019 | 14518 | 0.050 |
Why?
| | Reperfusion Injury | 1 | 2005 | 272 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 429 | 0.050 |
Why?
| | Cerebral Infarction | 1 | 2022 | 42 | 0.050 |
Why?
| | Fetus | 2 | 2020 | 773 | 0.050 |
Why?
| | Female | 7 | 2020 | 68776 | 0.050 |
Why?
| | Blood-Brain Barrier | 1 | 2022 | 132 | 0.050 |
Why?
| | Neurons | 2 | 2019 | 1511 | 0.040 |
Why?
| | Male | 4 | 2019 | 63681 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 2020 | 190 | 0.040 |
Why?
| | Ischemia | 1 | 2022 | 406 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 271 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5440 | 0.040 |
Why?
| | Memory | 1 | 2019 | 255 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 127 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 169 | 0.030 |
Why?
| | Memory Disorders | 1 | 2017 | 168 | 0.030 |
Why?
| | Long-Term Potentiation | 1 | 2017 | 197 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2005 | 1717 | 0.030 |
Why?
| | Neuronal Plasticity | 1 | 2017 | 280 | 0.030 |
Why?
| | Pregnancy | 2 | 2020 | 6402 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1968 | 0.030 |
Why?
| | Hippocampus | 1 | 2017 | 874 | 0.020 |
Why?
| | Embryo Loss | 1 | 2011 | 4 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2011 | 85 | 0.020 |
Why?
| | Cytokines | 2 | 2011 | 2017 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2011 | 226 | 0.020 |
Why?
| | Immunity | 1 | 2011 | 139 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2005 | 2406 | 0.020 |
Why?
| | Neurogenesis | 1 | 2011 | 124 | 0.020 |
Why?
| | Neural Stem Cells | 1 | 2011 | 143 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2011 | 263 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 5762 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2011 | 875 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6556 | 0.020 |
Why?
| | Rats | 2 | 2005 | 5500 | 0.020 |
Why?
| | Oxygen | 1 | 2011 | 915 | 0.020 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2005 | 91 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2005 | 92 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2005 | 118 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 2005 | 376 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 274 | 0.010 |
Why?
| | Chemokines | 1 | 2005 | 226 | 0.010 |
Why?
| | Macrophage Activation | 1 | 2005 | 189 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2005 | 811 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2391 | 0.010 |
Why?
| | Aged | 1 | 2022 | 22103 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1698 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1713 | 0.010 |
Why?
| | Child | 1 | 2019 | 20883 | 0.010 |
Why?
|
|
Dingman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|